Gilead (NASDAQ: GILD) CCO sells 28,000 shares under 10b5-1 plan
Rhea-AI Filing Summary
GILEAD SCIENCES, INC. (GILD) reported insider equity transactions by Chief Commercial and Corporate Affairs Officer Johanna Mercier. On August 17, 2026, she exercised options for 25,000 shares of common stock (23,110 at a $66.64 exercise price and 1,890 at $72.34). She then sold 28,000 shares of common stock in open-market transactions at prices ranging from $136.74 to $138.36 per share. The filing states these transactions were executed under a Rule 10b5-1 trading plan adopted on February 20, 2025.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
6 txns
Insider
Mercier Johanna
Role
Chief Comm & Corp Aff Officer
Sold
28,000 shs ($3.85M)
Approx. gross sale proceeds
$3.85M
Approx. exercise cost
$1.68M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-qualified Stock Option (Right to Buy) F1, F4 | 23,110 | $0.00 | $0.00 |
| Exercise | Non-qualified Stock Option (Right to Buy) F1, F4 | 1,890 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 23,110 | $66.64 | $1.54M |
| Exercise | Common Stock F1 | 1,890 | $72.34 | $137K |
| Sale | Common Stock F1, F2 | 16,530 | $137.365 | $2.27M |
| Sale | Common Stock F1, F3 | 11,470 | $138.0353 | $1.58M |
Holdings After Transaction:
Non-qualified Stock Option (Right to Buy) — 69,960 shares (Direct);
Common Stock — 118,234 shares (Direct)
Footnotes (4)
- F1. The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
- F2. Sale prices for the transactions reported range from $136.74 to $137.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F3. Sale prices for the transactions reported range from $137.75 to $138.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F4. The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Key Figures
Options Exercised - Shares: 25,000 shares
Option Exercise Price: $66.64 per share
Option Exercise Price: $72.34 per share
+5 more
8 metrics
Options Exercised - Shares
25,000 shares
Total underlying Gilead common stock from option exercises on August 17, 2026
Option Exercise Price
$66.64 per share
Exercise price for 23,110 non-qualified stock options converted to common stock
Option Exercise Price
$72.34 per share
Exercise price for 1,890 non-qualified stock options converted to common stock
Shares Sold
28,000 shares
Total Gilead common shares sold by Johanna Mercier on August 17, 2026
Sale Price
$137.3650 per share
Per-share price for sale of 16,530 Gilead common shares
Sale Price
$138.0353 per share
Per-share price for sale of 11,470 Gilead common shares
Rule 10b5-1 Plan Adoption Date
February 20, 2025
Adoption date of the trading plan governing the reported transactions
Vesting Schedule
25% at 1 year; 6.25% quarterly thereafter
Four-year vesting terms for the reported stock options
Key Terms
Non-qualified Stock Option, Rule 10b5-1 trading plan, vesting schedule
3 terms
Non-qualified Stock Option financial
"security_title: Non-qualified Stock Option (Right to Buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Rule 10b5-1 trading plan regulatory
"made pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
vesting schedule financial
"The options have a four-year vesting schedule. 25% vest"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
FAQ
What insider transactions did GILD report for Johanna Mercier on August 17, 2026?
Johanna Mercier exercised options for 25,000 GILD shares and sold 28,000 shares of common stock on August 17, 2026, in a sequence of option exercises followed by open-market sales.
How many GILD options did Johanna Mercier exercise and at what prices?
She exercised options covering 25,000 GILD shares: 23,110 shares at a $66.64 exercise price and 1,890 shares at $72.34 per share, converting them into common stock.
Were Johanna Mercier’s GILD transactions under a Rule 10b5-1 trading plan?
Yes. The filing states the reported transactions were made under a Rule 10b5-1 trading plan adopted on February 20, 2025, indicating they were pre-arranged rather than timed discretionarily.
What type of options did Johanna Mercier exercise in the GILD filing?
She exercised Non-qualified Stock Options (Right to Buy) that converted into an equal number of Gilead common shares, with expiration dates in 2029 and 2030 and a four-year vesting schedule described in the footnotes.
What vesting schedule applies to Johanna Mercier’s GILD stock options?
The options follow a four-year vesting schedule: 25% vest on the first anniversary of the grant date, and the remaining balance vests 6.25% quarterly thereafter until fully vested, according to the filing footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.
